BMY FY 2022 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$124B

FY 2022 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$46.2B-0.5% YoY

Gross Profit

$26.5B57.4% margin

Operating Income

$9.3B20.1% margin

Net Income

$6.3B13.7% margin

EPS (Diluted)

$2.95

Cash Flow

Operating Cash Flow

$13.1B

Free Cash Flow

$11.9B

Stock-Based Comp.

$457M

Balance Sheet

Total Assets

$96.8B

Total Liabilities

$65.7B

Stockholders' Equity

$31.1B

Cash & Equivalents

$9.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46.2B	$46.4B	-0.5%
Gross Profit	$26.5B	$26.8B	-1.0%
Operating Income	$9.3B	$9.5B	-2.8%
Net Income	$6.3B	$7.0B	-9.5%